in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—11 March 2014
7:53 AM MDT | March 11, 2014 | Deepti Ramesh
API producer ScinoPharm reports rise in profits and sales Active pharmaceutical ingredients (APIs) manufacturer ScinoPharm (Tainan, Taiwan) reports a 9% increase in net profits for the full year 2013, compared with 2012, to 1.27 billion New Taiwan dollars ($42 million). Full-year 2013 sales increased 11%, to NT$5.08 billion. APIs for oncological and central nervous system (CNS) treatments have achieved steady sales, ScinoPharm says. Sales of irinotecan, used for the treatment of colorectal cancer, have nearly tripled in 2013 compared to 2012, making it the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee